Rajiv Tayal
Newark Beth Israel Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Rajiv Tayal.
Catheterization and Cardiovascular Interventions | 2018
Daniel M Arnett; James C. Lee; Michael A. Harms; Kathleen Kearney; Mario Ramos; Bryn Smith; Emily C. Anderson; Rajiv Tayal; James M. McCabe
We sought to describe the caliber and vascular health of the subclavian and axillary arteries as related to their potential utilization in complex cardiovascular procedures.
International Journal of Vascular Medicine | 2016
Rajiv Tayal; Humayun Iftikhar; Benjamin LeSar; Rahul Patel; Naveen Tyagi; Marc Cohen; Najam Wasty
Objective. The use of the axillary artery as an access site has lost favor in percutaneous intervention due to the success of these procedures from a radial or brachial alternative. However, these distal access points are unable to safely accommodate anything larger than a 7-French sheath. To date no studies exist describing the size of the axillary artery in relation to the common femoral artery in a patient population. We hypothesized that the axillary artery is of comparable size to the CFA in most patients and less frequently diseased. Methods. We retrospectively reviewed 110 CT scans of the thoracic and abdominal aorta done at our institution to rule out aortic dissection in which the right axillary artery, right CFA, left axillary artery, and left CFA were visualized. Images were then reconstructed using commercially available TeraRecon software and comparative measurements made of the axillary and femoral arteries. Results. In 96 patients with complete data, the mean sizes of the right and left axillary artery were slightly smaller than the left and right CFA. A direct comparison of the sizes of the axillary artery and CFA in the same patient yielded a mean difference of 1.69 mm ± 1.74. In all patients combined, the mean difference between the axillary artery and CFA was 1.88 mm on the right and 1.68 mm on the left. In 19 patients (19.8%), the axillary artery was of the same caliber as the associated CFA. In 8 of 96 patients (8.3%), the axillary artery was larger compared to the CFA. Conclusions. Although typically smaller, the axillary artery is often of comparable size to the CFA, significantly less frequently calcified or diseased, and in almost all observed cases large enough to accommodate a sheath with up to 18 French.
Journal of Heart and Lung Transplantation | 2013
Rajiv Tayal; J. Pieretti; D.A. Baran
pro-apoptotic effects on plasma cells and thus decreases antibody production. In our case, bortezomib has shown efficacy as rescue therapy for recurrent AMR despite the fact that no DSAs have been detected. Beyond the treatment of AMR, bortezomib has also been used in desensitization therapies prior to transplantation. Bortezomib decreases levels of panel reactive antibodies (PRA) in sensitized patients. The patient has continued on a stable outpatient course at 12 months after treatment. The proteasome inhibitor–based therapy with bortezomib appears to be a promising therapeutic option for recurrent AMR.
Sage Open Medicine | 2018
Rajiv Tayal; M Zain Khakwani; Benjamin LeSar; Michael Sinclair; Afroditi Emporelli; Vadim Spektor; Marc Cohen; Najam Wasty
Background: Our previous work demonstrating great ease and predictability of cannulation of the major aortic arch branches with an upwardly pointing 3DR catheter, irrespective of aortic arch type, led us to hypothesize that centering or “cresting” of these vessels must occur along the superior most aspect of the aortic arch in a curvilinear fashion. Methods: We retrospectively analyzed 111 computed tomographic scans of the chest and thoracic aorta with intravenous contrast performed at our hospital between April 2011 and May 2012 utilizing TeraRecon image reconstruction software. Four studies were excluded due to poor image quality and/or surgical changes to native aortic architecture. Results: Of the 107 studies included, 104 (97.2%) demonstrated centering of the major aortic arch branches on a curvilinear line “cresting” the superior most aspect of the aortic arch irrespective of arch type. Of the three studies that did not demonstrate this “cresting,” two were found to have aberrant right subclavian arteries associated with a type I aortic arch, and one had an aberrant right common carotid associated with a type II aortic arch. Conclusion: Operators engaging major aortic arch branches need to be mindful of the fact that these vessels are indeed centered on a line “cresting” along the superior most aspect of the aortic arch, and any algorithm that, by taking this information into account, reduces catheter manipulation in the aortic arch could potentially result in a reduction in distal atheroembolic events.
International Journal of Angiology | 2017
Michael Amponsah; Rajiv Tayal; Zain Khakwani; Michael Sinclair; Najam Wasty
&NA; The “preclose” technique employing two Perclose (P) devices is well established for large‐bore artery (LBA) hemostasis. Occasionally, only one Perclose deploys successfully during the initial preclose because of arterial calcification necessitating the use of the crossover balloon technique to achieve hemostasis at the LBA. We sought to determine if the combined use of one Perclose and either one Angioseal or one Mynx vascular closure device (VCD) is a safe alternative closure technique large‐bore arteriotomy closure. In total, 40 patients underwent high‐risk percutaneous coronary intervention (HRPCI) with Impella support, of whom 38 had common femoral artery (CFA) arteriotomies and 2 underwent percutaneous axillary arteriotomy (AA). Prior to Impella insertion, one Perclose device was predeployed. At the end of HRPCI, Impella was removed and a 0.035″ wire was inserted through the Impella sheath. This sheath was then withdrawn over the wire, and partially deployed Perclose was fully deployed. A 6‐Fr sheath was advanced over a 0.035″ wire into the CFA or AA, achieving hemostasis and reducing the LBA to a 6‐Fr size. The 6‐Fr arteriotomy was closed with a 6‐Fr Mynx or Angioseal VCD. Patients were followed at day 1 and day 30. Hybrid closure was successful in 38 of 40 cases. In one case of Mynx balloon rupture, hemostasis was achieved with heparin reversal and manual compression. In the case of Perclose failure, crossover balloon tamponade at arteriotomy site and external manual compression achieved hemostasis. Patients were free of complications at day 1 and day 30. Hybrid closure with one Perclose and either one Mynx or one Angioseal VCD is safe and effective for LBA closure.
International Journal of Angiology | 2016
Najam Wasty; M. Z. Khakwani; Spas Kotev; Catalin Boiangiu; Omar Hasan; Manjusha Anna; Rajiv Tayal; Khalil Kaid; Gail Baker; Marc Cohen
Journal of the American College of Cardiology | 2013
Rajiv Tayal; Benjamin LeSar; Ahmed Seliem; Spas Kotev; Alan D. Weinberg; Afroditi Emporelli; Zafar Iqbal; Omar Hasan; Deepa Iyer; Gurinder Rana; Manjusha Anna; Humayun Iftikhar; Patricia Panfile; Marc Cohen; Najam Wasty
Journal of the American College of Cardiology | 2018
Mohammad Thawabi; Rajiv Tayal; Amer Hawatmeh; Marc Cohen; Najam Wasty
Journal of the American College of Cardiology | 2017
Daniel M Arnett; James R. Lee; Michael P. Harms; Mario Ramos; Rajiv Tayal; James M. McCabe
Journal of the American College of Cardiology | 2017
James M. McCabe; Amir Khaki; William Nicholson; Nimrod Blank; J. Aaron Grantham; William Lombardi; Rajiv Tayal